Monopar Therapeutics Inc. - Common Stock (NQ:MNPR)

69.27 -2.53 (-3.52%)

Delayed Quote Updated: 4:00 PM EDT, Oct 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Monopar Therapeutics Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Crude Oil Down 2%; Maravai LifeSciences Shares Spike Higher ↗

February 23, 2024

U.S. stocks traded mostly higher midway through trading, with the Dow Jones index jumping more than 100 points on Friday. The Dow traded up 0.36% to 39,209.32 while the NASDAQ rose 0.01% to 16,042.80....

Via Benzinga

Topics Stocks

Dow Surges Over 150 Points; AerCap Posts Upbeat Earnings ↗

February 23, 2024

U.S. stocks traded higher this morning, with the Dow Jones index jumping more than 150 points on Friday.

Via Benzinga

Topics Stocks

Dow Gains Over 400 Points; Keurig Dr Pepper Shares Fall After Q4 Results ↗

February 22, 2024

U.S. stocks traded higher toward the end of trading, with the Dow Jones index jumping more than 400 points on Thursday. The Dow traded up 1.13% to 39,048.47 while the NASDAQ rose 2.93% to 16,037.52....

Via Benzinga

Topics Stocks

What's Going On With Cancer-Focused Monopar Therapeutics Stock Today? ↗

February 22, 2024

Monopar Therapeutics soars 36% in premarket trading on robust volume. Exciting preclinical data reveals MNPR-101's potent anti-tumor efficacy in targeting uPAR-expressing cancers.

Via Benzinga

Recap: Monopar Therapeutics Q3 Earnings ↗

November 09, 2023

Via Benzinga

Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

February 22, 2024

Shares of Etsy, Inc.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

February 22, 2024

Via Benzinga

Crude Oil Rises 1%; US Jobless Claims Fall To 201,000 ↗

February 22, 2024

U.S. stocks traded higher midway through trading, with the Nasdaq Composite jumping around 300 points on Thursday. The Dow traded up 0.67% to 38,872.01 while the NASDAQ rose 2.36% to 15,949.22. The S&P...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

February 22, 2024

Via Benzinga

Monopar Announces Promising Preclinical Data for its MNPR-101 Radiopharma Program Targeting Advanced Cancers

February 22, 2024

From Monopar Therapeutics Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

February 21, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

February 20, 2024

Via Benzinga

Crude Oil Moves Lower; Summit Therapeutics Shares Plummet ↗

February 20, 2024

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling over 200 points on Tuesday. The Dow traded down 0.18% to 38,557.86 while the NASDAQ fell 1.30% to 15,570.84. The...

Via Benzinga

Topics Stocks

Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

February 20, 2024

Shares of Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter results.

Via Benzinga

Why Is Cancer Drug Focused Monopar Therapeutics Stock Trading Higher On Tuesday? ↗

February 20, 2024

Monopar Therapeutics surges 90% premarket with 3.94 million volume after HREC clearance for Phase 1 dosimetry trial (MNPR-101-Zr) in advanced cancers.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

February 20, 2024

Via Benzinga

Dow Dips Over 100 Points; US Leading Economic Index Falls In January ↗

February 20, 2024

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 1.5% on Tuesday. The Dow traded down 0.35% to 38,494.51 while the NASDAQ fell 1.51% to 15,537.95. The S&P 500...

Via Benzinga

Topics Stocks

Nasdaq Down 1%; Capital One Set To Buy Discover ↗

February 20, 2024

U.S. stocks traded lower this morning, with the Nasdaq Composite falling around 150 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.05% to 38,607.53 while the NASDAQ fell...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

February 20, 2024

Via Benzinga

Monopar Receives Clearance to Proceed with First-in-Human Phase 1 Trial of Novel Radiopharmaceutical MNPR-101-Zr in Advanced Cancers

February 20, 2024

From Monopar Therapeutics Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's After-Market Session ↗

January 12, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

January 11, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

December 29, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

December 06, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 16, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

November 13, 2023

Via Benzinga

Why Edible Garden Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

November 13, 2023

Edible Garden AG Incorporated (NASDAQ: EDBL) shares fell on Monday following third-quarter results.

Via Benzinga

Why StoneCo Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket ↗

November 13, 2023

StoneCo Ltd. (NASDAQ: STNE) shares rose in pre-market trading after the company reported upbeat results for its third quarter on Friday.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 13, 2023

Via Benzinga

Monopar Therapeutics Reports Third Quarter 2023 Financial Results and Recent Developments

November 09, 2023

MNPR-101 Radiopharma Program to Enter First-in-Human Studies Potentially As Early As December of This Year Camsirubicin Phase 1b Trial Efficacy and Safety Data Highlighted at the 2023 CTOS Annual...

From Monopar Therapeutics Inc.

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.